SEC Form 4 · accession 0001209191-18-041640

Neuronetics, Inc. · STIM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Jul 2, 2018

Accepted (ET)

Jul 5, 2018 · 4:32 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001227636

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Jul 2, 2018	C	8,483	—	A	84,065	D
Common Stock^F1	Jul 2, 2018	C	15,342	—	A	99,407	D
Common Stock^F1	Jul 2, 2018	C	9,525	—	A	108,932	D
Common Stock^F1	Jul 2, 2018	C	1,506	—	A	110,438	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series D Covertible Preferred Stock^F1	—	Jul 2, 2018	C	8,483	D	—	—	Common Stock	8,483	0	D
Series E Covertible Preferred Stock^F1	—	Jul 2, 2018	C	15,342	D	—	—	Common Stock	15,342	0	D
Series F Covertible Preferred Stock^F1	—	Jul 2, 2018	C	9,525	D	—	—	Common Stock	9,525	0	D
Series G Covertible Preferred Stock^F1	—	Jul 2, 2018	C	1,506	D	—	—	Common Stock	1,506	0	D
Stock Option Grant (Right to Buy)^F2	$5.22	Jul 2, 2018	A	10,959	A	—	Apr 25, 2028	Common Stock	10,959	10,959	D

F1Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock, Series F Convertible Preferred Stock and Series G Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering.
F2The performance criterion for vesting of this option was met upon the closing of the Issuer's initial public offering. One twelfth (1/12th) of the shares subject to the option vested or shall vest monthly commencing on March 16, 2018, subject to Reporting Person continuing to provide service through each such date.